Wang Chengbin, Jin Lee Jeong, Jung Hae-Hyuk, Zuo Zhiyi
Department of Anesthesiology, University of Virginia Health System, One Hospital Drive, Charlottesville, VA 22908-0710, USA.
Brain Res. 2007 Jun 4;1152:201-8. doi: 10.1016/j.brainres.2007.03.030. Epub 2007 Mar 15.
A prior exposure to the volatile anesthetic isoflurane has been shown to induce neuroprotection in rats. This phenomenon is called preconditioning. We designed this study to determine whether the potency of volatile anesthetics in inducing neuropreconditioning is related to their potency to induce anesthesia. Cerebellar slices of adult male Sprague-Dawley rats were exposed to various concentrations of isoflurane, halothane, sevoflurane, desflurane or the nonimmobilizer 1,2-dichlorohexafluorocyclobutane for 15 min, followed by a 15-min drug-free period, and then were subjected to oxygen-glucose deprivation for 10 min at 37 degrees C. After a 5-h recovery at 37 degrees C, brain slices were used for quantification of cell injury by spectrophotometric measurement of formazan produced from 2,3,5-triphenyltetrazolium chloride. All four volatile anesthetics induced a concentration-dependent preconditioning effect. The EC50 for this effect induced by isoflurane, halothane, sevoflurane or desflurane was 221, 173, 184 and 929 microM, respectively. This EC50 was linearly correlated with the aqueous concentration of one minimum alveolar concentration. The volatile anesthetic preconditioning-induced neuroprotection was abolished by DL-threo-beta-hydroxyaspartic acid, DL-threo-beta-benzyloxyaspartate or dihydrokainate, glutamate transporter inhibitors. The volatile nonimmobilizer 1,2-dichlorohexafluorocyclobutane at any concentrations tested in the study did not induce a significant preconditioning effect. Isoflurane preconditioning did not change the oxygen-glucose deprivation-induced glutamate accumulation. These results suggest that the preconditioning-induced neuroprotection by volatile anesthetics is not agent-specific. Mechanisms that are involved in inducing anesthesia may contribute to the induction of preconditioning effect by volatile anesthetics. Modification of glutamate transporter activity may be one of such mechanisms to induce these protective effects.
先前接触挥发性麻醉剂异氟烷已被证明可在大鼠中诱导神经保护作用。这种现象被称为预处理。我们设计了这项研究,以确定挥发性麻醉剂诱导神经预处理的效力是否与其诱导麻醉的效力相关。将成年雄性Sprague-Dawley大鼠的小脑切片暴露于不同浓度的异氟烷、氟烷、七氟烷、地氟烷或非麻醉剂1,2-二氯六氟环丁烷中15分钟,随后有15分钟的无药期,然后在37℃下进行10分钟的氧-葡萄糖剥夺。在37℃恢复5小时后,使用脑切片通过分光光度法测量由氯化三苯基四氮唑产生的甲臜来定量细胞损伤。所有四种挥发性麻醉剂均诱导出浓度依赖性的预处理效应。异氟烷、氟烷、七氟烷或地氟烷诱导此效应的半数有效浓度(EC50)分别为221、173、184和929微摩尔。该EC50与一个最低肺泡浓度的水相浓度呈线性相关。挥发性麻醉剂预处理诱导的神经保护作用被谷氨酸转运体抑制剂DL-苏式-β-羟基天冬氨酸、DL-苏式-β-苄氧基天冬氨酸或二氢海因酸盐消除。在该研究中测试的任何浓度下,挥发性非麻醉剂1,2-二氯六氟环丁烷均未诱导出显著的预处理效应。异氟烷预处理并未改变氧-葡萄糖剥夺诱导的谷氨酸积累。这些结果表明,挥发性麻醉剂预处理诱导的神经保护作用并非药物特异性的。参与诱导麻醉的机制可能有助于挥发性麻醉剂诱导预处理效应。谷氨酸转运体活性的改变可能是诱导这些保护作用的此类机制之一。